Protara Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -83 | -83 | ||
EBITDA | -14,230 | -12,246 | -10,578 | -11,768 |
EBIT | -14,312 | -12,330 | -10,661 | -11,851 |
Net Income | -12,769 | -11,219 | -9,513 | -11,095 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -9,308 | -8,442 | -7,742 | -10,379 |
Cash | 162,798 | 51,757 | 89,581 | 52,231 |
Basic Shares | 21,461 | 22,329 | 21,233 | 11,420 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -341 | -247 | -1,167 | |
EBITDA | -49,154 | -43,272 | -64,568 | -46,085 |
EBIT | -43,613 | -64,815 | -47,252 | |
Net Income | -44,596 | -40,420 | -64,815 | -47,135 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -35,871 | -37,602 | -26,577 | -35,098 |
Cash | 162,798 | 39,586 | 24,127 | 35,724 |
Basic Shares | 20,592 | 11,331 | 11,259 | 11,232 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.43 |
2024-09-30 | -$0.50 |
2024-06-30 | -$0.45 |
2024-03-31 | -$0.97 |
